Court Rejects Anthem’s Attempt to Relitigate Arbitration Losses Under No Surprises Act

Court Rejects Anthem’s Attempt to Relitigate Arbitration Losses Under No Surprises Act

HEALTH CARE un-covered
HEALTH CARE un-coveredApr 20, 2026

Key Takeaways

  • Federal court barred Anthem from re‑litigating IDR arbitration outcomes.
  • Ruling affirms narrow judicial review scope under No Surprises Act.
  • Anthem may appeal, but state‑law claims remain open in California.
  • Parallel lawsuits by Blue Cross and UnitedHealthcare continue nationwide.
  • Fifth Circuit case could alter benchmark payment calculations, affecting patient costs.

Pulse Analysis

The No Surprises Act, enacted in 2020, was designed to eliminate unexpected out‑of‑network medical bills by creating an Independent Dispute Resolution (IDR) process. Under IDR, insurers and providers submit their best offers, and a neutral arbitrator determines a fair payment. This mechanism was intended to be the final step, reducing litigation and providing certainty for both patients and providers.

In the recent California case, Magistrate Judge Karen Scott ruled that Anthem could not use federal courts to challenge IDR decisions unless there is clear evidence of corruption, fraud, or undisclosed bias. She emphasized that the Act already allows participants to flag ineligible disputes directly to arbitrators, and that expanding judicial review would undermine the streamlined process Congress established. Anthem’s arguments about arbitrator fee incentives were rejected as a matter of congressional design, not misconduct.

The ruling has broader implications for the health‑insurance industry. While Anthem plans to appeal, the decision sets a precedent that may limit similar challenges across other jurisdictions, forcing insurers to rely on the existing IDR framework. Ongoing lawsuits by Blue Cross Blue Shield affiliates and UnitedHealthcare will now navigate without the prospect of federal court overrides, and a separate Fifth Circuit case could reshape how benchmark payments are calculated, potentially raising out‑of‑pocket costs for patients. Stakeholders should monitor the Ninth Circuit appeal, as its outcome could further define the balance between arbitration finality and judicial oversight.

Court Rejects Anthem’s Attempt to Relitigate Arbitration Losses Under No Surprises Act

Comments

Want to join the conversation?